Literature DB >> 22587635

Predictive value of symptoms for quality of life in first-episode schizophrenia.

Preeta Kaur Chugh1, Harmeet S Rehan, K E S Unni, Ravinder K Sah.   

Abstract

BACKGROUND: Management of the disease symptomatology impacts the long-term functioning and quality of life (QOL) in psychotic patients. AIM: The aim of this research was to study the association between psychiatric symptoms (positive, negative and general psychopathology symptoms) and QOL in first-episode schizophrenia patients.
METHODS: Fifty-five first-episode drug-naïve schizophrenia outpatients were recruited from a tertiary care hospital in New Delhi, India. WHOQOL-Bref (World Health Organization Quality of Life) Scale was used to assess multi-dimensional domains of QOL (physical, psychological, social and environmental health). The patients were evaluated clinically using PANSS and followed up for 6 months. Multivariate analyses were carried out to outline the symptoms which are predictive of QOL in these patients.
RESULTS: Physical well-being as assessed with WHOQOL-Bref is significantly impacted by the positive, negative and general psychopathology symptoms of the disease. General psychopathology symptoms demonstrated a strong relationship with different facets of QOL. These symptoms are predictive of physical (P=0.025) and psychological health (P=0.026), social relationships (P=0.009) and environmental QOL (P=0.022).
CONCLUSIONS: The general psychopathology symptoms significantly impact QOL in a diverse manner. Negative symptoms have a greater influence than positive symptoms on subjective QOL. CLINICAL IMPLICATIONS: The antipsychotics focus on primary positive and negative disease symptoms. There is a need to develop a holistic approach (target non-psychotic symptoms intensively) in the disease management to prevent further long-term impairment of QOL.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22587635     DOI: 10.3109/08039488.2012.687768

Source DB:  PubMed          Journal:  Nord J Psychiatry        ISSN: 0803-9488            Impact factor:   2.202


  5 in total

1.  Reliability and Validity of the Short Version of Udvalg for Kliniske Undersogelser in Antipsychotic Treatment.

Authors:  Kun-Po Chen; For-Wey Lung
Journal:  Psychiatr Q       Date:  2017-12

2.  Quality of life in patients with schizophrenia: the impact of socio-economic factors and adverse effects of atypical antipsychotics drugs.

Authors:  Aurigena Antunes de Araújo; Diego de Araújo Dantas; Gemma Galgani do Nascimento; Susana Barbosa Ribeiro; Katarina Melo Chaves; Vanessa de Lima Silva; Raimundo Fernandes de Araújo; Dyego Leandro Bezerra de Souza; Caroline Addison Carvalho Xavier de Medeiros
Journal:  Psychiatr Q       Date:  2014-09

3.  Negative symptoms, anxiety, and depression as mechanisms of change of a 12-month trial of assertive community treatment as part of integrated care in patients with first- and multi-episode schizophrenia spectrum disorders (ACCESS I trial).

Authors:  Stefanie J Schmidt; Matthias Lange; Daniel Schöttle; Anne Karow; Benno G Schimmelmann; Martin Lambert
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-05-24       Impact factor: 5.270

4.  Quality of life in patients with schizophrenia: A 2-year cohort study in primary mental health care in rural China.

Authors:  Xiao-Yan He; Christine Migliorini; Zhuo-Hui Huang; Fei Wang; Rui Zhou; Zi-Lang Chen; Yao-Nan Xiao; Qian-Wen Wang; Shi-Bin Wang; Carol Harvey; Cai-Lan Hou
Journal:  Front Public Health       Date:  2022-09-07

5.  Targets, attitudes, and goals of psychiatrists treating patients with schizophrenia: key outcome drivers, role of quality of life, and place of long-acting antipsychotics.

Authors:  Andrea de Bartolomeis; Andrea Fagiolini; Marco Vaggi; Claudio Vampini
Journal:  Neuropsychiatr Dis Treat       Date:  2016-01-11       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.